Northwest Biotherapeutics reported $200K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Agenus USD 34.2M 3.97M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Celldex Therapeutics USD 121K 769K Dec/2025
Eisai JPY 219.94B 22.58B Dec/2025
Infinity Pharmaceuticals USD 583K 148K Jun/2023
Merck USD 16.4B 880M Dec/2025
Northwest Biotherapeutics USD 200K 245K Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Plus Therapeutics USD 1.37M 30K Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025